Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_assertion description "[Here we report that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1, BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_assertion evidence source_evidence_literature NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_assertion SIO_000772 21720365 NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_assertion wasDerivedFrom befree-20140225 NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_assertion wasGeneratedBy ECO_0000203 NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP509250.RAR0I-YrHlkXHVP9pl80KhbZRGEPcxY2muqXYWIR2n7cA130_provenance.